Metformine Hcl Teva (Metformin Hydrochloride)

Metformin Hydrochloride lowers blood glucose primarily by suppressing hepatic gluconeogenesis, which reduces the amount of glucose released by the liver. It also increases peripheral insulin sensitivity, enhancing glucose uptake in muscle and fat tissue, and modestly reduces intestinal glucose absorption, together helping to normalize glycaemic levels.

The appropriate dose of Metformine Hcl Teva is determined individually by a qualified prescriber based on the patient’s clinical condition, renal function, and response to therapy. Dosage adjustments are made according to therapeutic goals and tolerability, and patients should follow the prescribing healthcare professional’s instructions.

Safety of metformin during pregnancy or lactation should be evaluated by a healthcare professional. While metformin is sometimes continued in pregnancy for specific indications, its use is decided case‑by‑case. Breastfeeding mothers should discuss potential exposure with their physician, as metformin does pass into breast milk in small amounts.

To request Metformine Hcl Teva, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformine Hcl Teva belongs to the biguanide class, differing from sulfonylureas, DPP‑4 inhibitors or SGLT2 inhibitors. Unlike insulin‑secretagogues, metformin does not stimulate insulin release, reducing hypoglycaemia risk. It is often used as first‑line therapy because of its efficacy, weight‑neutral profile and low cost compared with newer agents.

Metformine Hcl Teva should be stored at room temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged or the tablets appear discoloured.

Metformine Hcl Teva is taken orally, usually with meals to minimise gastrointestinal upset. Tablets are swallowed whole with a glass of water. The exact timing and frequency are prescribed by the treating clinician, who may start with a low dose and titrate upward based on glycaemic response.

The most serious risk is lactic acidosis, a rare but potentially fatal condition that can occur in patients with significant renal impairment, hepatic disease, or excessive alcohol intake. Other serious concerns include severe skin reactions and vitamin B12 deficiency with long‑term use, which require regular monitoring.

Metformine Hcl Teva is contraindicated in patients with severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those with known hypersensitivity to metformin. Caution is also advised for individuals with significant liver disease or congestive heart failure.